The goal of Dozee’s partnership with BII is to improve access to healthcare across India and alleviate the workload of healthcare workers, reduce nurse burnout and fatigue in hospital wards
SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Investment with representation on the Board of Directors and technical know-how
Multiples is the first private equity (PE) investor in the company
Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Partnership with Modality, award-winning GP super partnership
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Subscribe To Our Newsletter & Stay Updated
